申请人:Novo Nordisk A/S
公开号:US06232310B1
公开(公告)日:2001-05-15
The present invention relates to fused 1,4-thiazine-2-carbonitrile derivatives, compositions thereof and methods for preparing the compounds.
The compounds are useful in the treatment of diseases of the central nervous system, the cardiovascular system, the pulmonary system, the gastrointestinal system and the endocrinological system.
本发明涉及融合的1,4-噻嗪-2-碳腈衍生物,其组合物以及制备这些化合物的方法。这些化合物在治疗中枢神经系统、心血管系统、呼吸系统、消化系统和内分泌系统疾病方面具有用途。